Open-label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With Epilepsy
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
Keppra injection is approved in the US as adjunctive therapy in the treatment of partial
onset seizures in adults with epilepsy. The objective of the current study is to assess the
safety, tolerability, and pharmacokinetics, of this formulation in children aged 1 month to 4
years.